Develops drugs for central nervous system disorders.
Jun 2026Revenue $3.39M/yrExpenses $23.3M/yr
No trendCash runway ≈ 1.3 years from Jun 2026
Figures by year
When will NRX Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $3.39M and expenses $23.3M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.23M | $17.4M | −$16.2M |
| Dec 2024 | $0.00 | $18.5M | −$18.5M |
| Dec 2023 | $0.00 | $27.8M | −$27.8M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.